Abstract

Aim: We aimed to estimate the disease burden and risk factors attributable to ovarian cancer, and epidemiological trends at global, regional, and national levels.Methods: We described ovarian cancer data on incidence, mortality, and disability-adjusted life-years as well as age-standardized rates from 1990 to 2017 from the Global Health Data Exchange database. We also estimated the risk factors attributable to ovarian cancer deaths and disability-adjusted life-years. Measures were stratified by region, country, age, and socio-demographic index. The estimated annual percentage changes and age-standardized rates were calculated to evaluate temporal trends.Results: Globally, ovarian cancer incident, death cases, and disability-adjusted life-years increased by 88.01, 84.20, and 78.00%, respectively. However, all the corresponding age-standardized rates showed downward trends with an estimated annual percentage change of −0.10 (−0.03 to 0.16), −0.33 (−0.38 to −0.27), and −0.38 (−0.32 to 0.25), respectively. South and East Asia and Western Europe carried the heaviest disease burden. The highest incidence, deaths, and disability-adjusted life-years were mainly in people aged 50–69 years from 1990 to 2017. High fasting plasma glucose level was the greatest contributor in age-standardized disability-adjusted life-years rate globally as well as in all socio-demographic index quintiles and most Global Disease Burden regions. Other important factors were high body mass index and occupational exposure to asbestos.Conclusion: Our study provides valuable information on patterns and trends of disease burden and risk factors attributable to ovarian cancer across age, socio-demographic index, region, and country, which may help improve the rational allocation of health resources as well as inform health policies.

Highlights

  • Ovarian cancer (OC) is the most common cancer in females worldwide and has a high mortality rate [1,2,3]

  • We evaluated the burden and risk factors attributable to OC by location, social-development index (SDI), and age, providing valuable information on the distribution and trends of incident cases, deaths, disability-adjusted-life-years (DALYs), and risk factors, which could be beneficial to the improvement of health resources allocation and in the informed formulation of policies

  • The latest research about the global disease burden of women cancer revealed that the incidence, deaths, and DALYs of ovarian cancer were 294,420, 198,410, and 5,359,740, respectively in 2019 globally which showed increases from 2017 [24]

Read more

Summary

Introduction

Ovarian cancer (OC) is the most common cancer in females worldwide and has a high mortality rate [1,2,3]. Around 290,000 new OC cases (3.4% of all new cancer cases in females) have been diagnosed annually [3]. Based on the latest global cancer statistics published in 2018, the age-standardized incidence rate (ASIR) and death rate (ASDR) of OC were 6.6 and 3.9 per 100,000 people, respectively. Epidemiological data from Saudi Arabia [4], China [5], and India [6] showed a remarkable OC burden with associated incidence and mortality. The Global Burden of Disease (GBD) studies provide global, regional, and countryspecific epidemiological data of diseases and injuries showing the burden, distribution, and trends in different countries and regions [7,8,9]. There are no comprehensive and comparable assessments of incidence, mortality, disability, and epidemiological trends of OC at the global scale or in most regions

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call